These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9133469)

  • 1. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a Cooperative Clinical Trials in Transplantation pilot study.
    Transplantation; 1997 Apr; 63(8):1087-95. PubMed ID: 9133469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.
    Transplantation; 1997 May; 63(9):1243-51. PubMed ID: 9158016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Jolliffe LK; Colvin RB
    Surgery; 1990 Aug; 108(2):406-13; discussion 413-4. PubMed ID: 2382234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys.
    Mourad GJ; Preffer FI; Wee SL; Powelson JA; Kawai T; Delmonico FL; Knowles RW; Cosimi AB; Colvin RB
    Transplantation; 1998 Mar; 65(5):632-41. PubMed ID: 9521196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative pilot study (report 1). Cooperative Clinical Trials in Transplantation (CCTT) Research Group.
    Transplant Proc; 1995 Feb; 27(1):863. PubMed ID: 7879208
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-CD4 monoclonal antibody therapy.
    Delmonico FL; Cosimi AB
    Clin Transplant; 1996 Oct; 10(5):397-403. PubMed ID: 8930451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
    Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
    Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients.
    Wee SL; Stroka DM; Preffer FI; Jolliffe LK; Colvin RB; Cosimi AB
    Transplantation; 1992 Mar; 53(3):501-7. PubMed ID: 1532265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts.
    Kovarik J; Wolf P; Cisterne JM; Mourad G; Lebranchu Y; Lang P; Bourbigot B; Cantarovich D; Girault D; Gerbeau C; Schmidt AG; Soulillou JP
    Transplantation; 1997 Dec; 64(12):1701-5. PubMed ID: 9422405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
    Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients.
    Powelson JA; Knowles RW; Delmonico FL; Kawai T; Mourad G; Preffer FK; Colvin RB; Cosimi AB
    Transplantation; 1994 Mar; 57(6):788-93. PubMed ID: 7908767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F; Ramos E; Brattstrom C; Cho S; Ekberg H; Grinyo J; Johnson R; Kuypers D; Stuart F; Khanna A; Navarro M; Nashan B
    Transplantation; 2001 May; 71(9):1282-7. PubMed ID: 11397963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies.
    Delmonico FL; Knowles RW; Colvin RB; Cavender DE; Kawai T; Bedle M; Stroka D; Preffer FI; Haug C; Cosimi AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):784-5. PubMed ID: 8438479
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients.
    Kandus A; Grego K; Bren AF
    Ther Apher Dial; 2005 Jun; 9(3):262-4. PubMed ID: 15967003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhuman primate responses to murine and humanized OKT4A.
    Delmonico FL; Cosimi AB; Kawai T; Cavender D; Lee WH; Jolliffe LK; Knowles RW
    Transplantation; 1993 Apr; 55(4):722-8. PubMed ID: 8475542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group.
    Thistlethwaite JR; Nashan B; Hall M; Chodoff L; Lin TH
    Transplantation; 2000 Sep; 70(5):784-90. PubMed ID: 11003358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
    Kahan BD; Rajagopalan PR; Hall M
    Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at risk for delayed graft function.
    Hong JC; Kahan BD
    Transplantation; 2001 May; 71(9):1320-8. PubMed ID: 11397971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of OKT4A (a murine monoclonal anti-CD4 antibody) in human organ transplantation: initial clinical experience.
    Norman DJ; Bennett WM; Cobanoglu A; Hershberger R; Hosenpud JD; Meyer MM; Misiti J; Ott G; Ratkovec R; Shihab F
    Transplant Proc; 1993 Feb; 25(1 Pt 1):802-3. PubMed ID: 8438490
    [No Abstract]   [Full Text] [Related]  

  • 20. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients.
    Cosimi AB; Delmonico FL; Wright JK; Wee SL; Preffer FI; Bedle M; Colvin RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):501-3. PubMed ID: 1990600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.